After Pfizer Deal, Biocon CEO Reflects On Journey From Beer To Drugs
This article was originally published in PharmAsia News
Executive Summary
After landing deal with Pfizer Inc. for supplies of insulin, India's Biocon Ltd. CEO Kiran Mazumdar-Shaw reflects on her beginnings in drug development